Target intelligence / Profile preview

Mitochondrial ribosomal protein L53 pseudogene 1 (MRPL53P1)

Target: MRPL53P1
Molecular classification: Other (pseudogene)

Overview

Mitochondrial ribosomal protein L53 pseudogene 1 (MRPL53P1) is a human processed pseudogene, not encoding a functional protein product. It is derived from the mitochondrial large ribosomal protein gene MRPL53, but has been inactivated by mutations during evolution—such as changes in the start codon—that prevent translation[4]. Processed pseudogenes often arise via retrotransposition and typically lack intronic structure or protein-coding capacity. While some pseudogenes have regulatory RNA roles, there is no specific evidence of functional significance, disease association, or druggability for MRPL53P1[4].

Other names: MRPL53P1Mitochondrial ribosomal protein L53 pseudogene 1

Mechanism of action

None known.

Biological functions

Other (Pseudogenes are generally considered non-functional at the protein level. However, in rare cases, some pseudogenes can act as RNA decoys or compete for microRNA binding, but this is not specifically described for MRPL53P1[4].)

Disease associations

Other (No evidence links MRPL53P1 directly to disease. General studies have shown that certain pseudogenes can affect gene regulation and play a role in disease only if they act as regulatory RNAs, but no such data exists for MRPL53P1[4].)

Safety considerations

None known.

Interacting drugs

None known.

Biomarkers

None known.

Beyond the preview

Go deeper on Mitochondrial ribosomal protein L53 pseudogene 1 (MRPL53P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial ribosomal protein L53 pseudogene 1 (MRPL53P1).

Explore the full profile